Literature DB >> 11027824

Oral immunization with size-purified microsphere beads as a vehicle selectively induces systemic tolerance and sensitization.

Y Matsunaga1, Y Wakatsuki, Y Tabata, H Kawasaki, T Usui, M Yoshida, T Itoh, S Habu, T Kita.   

Abstract

Oral administration of antigens has long been recognized as a method to prevent or delay the onset of diseases associated with untoward immune responses to self and non-self antigens. Although oral administration of antigens offers a convenient way to induce systemic tolerance, its therapeutic potential has been seriously limited by the fact that it requires repeated feeding of a large amount of antigens and that it may deteriorate ongoing autoimmune diseases when autoantigens are employed. We have previously shown that orally administered poly-D,L-lactic acid (PDLLA) microspheres containing an antigen were selectively distributed to Peyer's patches (PP) and systemic lymphoid tissues according to their diameter and then released the antigen over a long period of time. We now report that a single dose of intragastric immunization with a PDLLA microsphere 7-10 micrometer in diameter and containing 2 mg of OVA was as effective as 100 mg of water soluble OVA to suppress OVA-specific IgG and DTH response. This was associated with a large increase of Interferon-gamma production by PPT cells stimulated with an antigen and a small increase in secretory IgA specific to OVA. In contrast, administration of an antigen encapsulated in microspheres 3-4 microm in diameter led to an enhanced OVA-specific IgG response and no significant increase in OVA-specific secretory IgA. Thus, by utilizing microspheres of an appropriate diameter as a vaccination vehicle, we were able to selectively induce both systemic tolerance and sensitization by oral ingestion of single low dose of an antigen.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11027824     DOI: 10.1016/s0264-410x(00)00120-1

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  3 in total

Review 1.  Oral passive IgY-based immunotherapeutics: a novel solution for prevention and treatment of alimentary tract diseases.

Authors:  Shofiqur Rahman; Sa Van Nguyen; Faustino C Icatlo; Kouji Umeda; Yoshikatsu Kodama
Journal:  Hum Vaccin Immunother       Date:  2013-01-14       Impact factor: 3.452

2.  Oral Administration of Lactococcus lactis Expressing Synthetic Genes of Myelin Antigens in Decreasing Experimental Autoimmune Encephalomyelitis in Rats.

Authors:  Kaja Kasarello; Barbara Kwiatkowska-Patzer; Andrzej W Lipkowski; Jacek K Bardowski; Agnieszka K Szczepankowska
Journal:  Med Sci Monit       Date:  2015-05-31

Review 3.  Synthetic Biodegradable Microparticle and Nanoparticle Vaccines against the Respiratory Syncytial Virus.

Authors:  Patricia A Jorquera; Ralph A Tripp
Journal:  Vaccines (Basel)       Date:  2016-12-02
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.